Michal Begin

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biokine Therapeutics Ltd.. Active years: 2013-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michal Begin. Retrieved from https://idiyas.com/inventor/michal-begin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)

Company Filing History:

3 out of 35

Biokine Therapeutics Ltd.

patents

Years Active: 2013-2014

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8765683 - T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy (2014-07-01),

2. 8663651 - T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation (2014-03-04),

3. 8455450 - Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof (2013-06-04),

Profile summary based on public USPTO records.